Watch all 5 days here
With 10 incredibly current sessions, Wounds Week gives a chance for the wound care community to come together and engage in key education free of charge.

Each session will have a live Q&A so participants can ask questions of the experts and really feel part of the event.
This Series Has 5 Sections
  • Dr Grace Parfitt, Senior Lecturer in Podiatry, University of Huddersfield and James Linsley, High Risk Lead Podiatrist, NHS
    Larval debridement therapy: clinical considerations in chronic wounds
    Larval therapy is becoming increasingly more popular within the management of chronic wounds due to its supplementary therapeutic effects, including antimicrobial properties, alongside its primary mode of action of debridement. The session will explore the practical application of larval debridement therapy in chronic wounds. It will identify and discuss its advantages, barriers, and solutions in clinical practice.
  • Ojan Assadian, Medical Director of the Hospital Neunkirchen, Austria
    Tuesday: Clinical considerations for topical wound antisepsis or systemic antibiotic therapy
    Innovations in Skin Tears 18:00 - 18:30 GMT

    Maintaining skin health and preventing skin barrier damage are integral parts of daily nursing practice across the continuum of healthcare settings. The maintenance of skin integrity is an important quality indicator that contributes to positive patient outcomes and is accepted as more cost-effective compared to wound treatment. Healthy skin is strong, resilient and has an extensive capacity for repair. However, due to ageing and altered physiology, skin integrity may become compromised in certain populations. Individuals with an enhanced skin vulnerability are at increased risk of a range of skin lesions, with skin tears being one of the most prevalent conditions. Despite their considerable impact, skin tears are often under-recognised and poorly reported in clinical practice, leading to suboptimal prevention and delayed or inappropriate management. This presentation will provide an update about skin tear development, prevention, and treatment.

    Skin Tear: Vulnerable skin, risks of adhesives, edema and wound healing 18:30 - 19:00 GMT

    This session will discuss the importance of accurate assessment and management when caring for individuals with skin tears. An exploration of potential barriers that may impede the application of theory into practice will be highlighted and strategies to help clinicians overcome these barriers will be discussed. Consideration of solutions will be offered that may help clinicians implement evidence based medicine into care settings. The concept of prevention, treatment and recovery will be presented as an aid in managing skin integrity.

    Both talks are kindly sponsored by Essity.

    To apply for CPD after watching on-demand, please email

  • Prof. Karen Ousey, Prof. Barbara Conway, Dr. David Armstrong, Dr. Serge Bohbot, Prof. Michael Edmonds, and Dr. Marco Meloni
    Wednesday: Innovations in DFU management
    Innovations in DFU management 18:00 - 18:30 GMT

    Every 1.2 seconds, someone in the world with diabetes develops a limb-threatening foot wound. Every 20 seconds, someone with a wound undergoes an amputation. Three- and five-year mortality amongst people with amputation exceeds all but the most aggressive cancers. With these data as a backdrop, we will review the current state of play regarding treatment of the diabetic foot and wounds in the developed and developing world. We will explore policy factors associated with the team approach to amputation prevention as well as tips for the structure of successful teams, both at SALSA and worldwide.

    The concept of the “Toe and Flow” philosophy of prevention will be explored. Subsequently, emphasis will be placed on specific successes and failures and perhaps a way forward toward extending ulcer-free-days in remission. We also explore the use of novel new technology merging consumer electronics with medical devices in an effort to prevent problems before they start. Further information regarding this lecture including video, manuscripts and blog available at:

    Innovation in diabetic foot care: How can R&D improve clinical outcomes ? 18:30 - 19:00 GMT

    Because diabetic foot ulcers are a source of suffering, our mission at Urgo Medical is to support healthcare professionals every day in healing their patients and making a difference by:

    Leading with science : Delivering innovative local treatments backed by robust clinical evidence thanks to continuous investment in R&D

    Being healthcare professional partners in diabetic foot management : Working closely with the scientific community to develop effective, simple and cost effective treatments in real life & educational programs to constantly improve knowledge in wound care

    Putting patients at the heart : Focusing on patient outcomes improvement by adapting to their needs and empowering them through education

    To apply for CPD after watching on-demand, please email
  • Prof. Barbara Conway, University of Huddersfield, Prof. Karen Ousey, Institute of Skin Integrity and Infection Prevention and Dot Weir, Saratoga Hospital Medical Group Wound Healing
    Thursday: Innovations in diagnostics and wound management products
    This webinar is kindly sponsored by Molnlycke.

    The practice of wound management has evolved over the years enabling providers to further understand the barriers to healing and many consensus papers have been published providing guidance in the various aspects of caring for difficult to heal wounds. Technologies have been developed to aid in the early recognition of impediments to healing, overcome obstacles in care as well as improved accuracy in wound evaluation and documentation. Finally, innovations in materials to aid in wound cleansing and topical management have improved local care.

    Many chronic wounds are complicated by the presence of spaces that may not be initially evident in the form of undermining, tracts and tunnels. A careful and thorough exploration of the wound is critical in order to identify these areas. Optimal wound management dicates that the practitioner continually assess and treat these areas to avoid the accumulation of exudates, debris and bacteria. This presentation will define these areas, discuss how to locate and assess them, and use cases to illustrate management options following optimal wound healing practices.

    To apply for CPD after watching on-demand, please email
  • Prof. Amit Gefen, Tel Aviv University, Prof. Barbara Conway, University of Huddersfield, Prof. Karen Ousey, Institute of Skin Integrity and Infection Prevention and Sarah Gardner, WoundsMatter
    Friday: Innovations in lower limb management
    Holding back the tide: Why assessment is vital to exudate management of the lower limb 18:00 - 18:35 GMT

    Clinicians are often faced with patients presenting with lower limb conditions that are complicated by high levels of exudate. We often hear the term ‘wet legs’ being referred to and we know that leg ulceration can fail to heal when the wounds are chronic and peri-wound skin is damaged from unmanaged exudate. Unfortunately, the role of exudate is often misunderstood and therefore frequently overlooked as part of the assessment process. This can then lead to ineffective care and delayed healing. This session will explore the ‘science’ behind exudate, what you need to consider as part of your assessment process and discuss some of the solutions to effective exudate management of lower limb conditions.

    The desired performances of wound dressings for an effective exudate management 18:35 - 19:05 GMT

    A crucial aspect in effective wound care is exudate management. Excessive presence of exudate fluids typically involve wound exposure to elevated inflammatory cytokine levels and proteolytic enzymes. Pooling of exudate fluids also creates a medium for pathogen growth. Each and all of these factors may delay the healing. Peri-wound tissues may further be negatively affected by excess exudates, which wet newly regenerated tissues or periwound skin, resulting in tissue cross-contamination, additional inflammatory irritation or maceration of the periwound skin.

    On the other hand, a dressing must not drain the wound-bed completely, as moisture is required as the medium for transport of nutrients and immunological factors to the healing tissues and is essential for proliferation and migration of the cells which form the re-epithelialization. A good wound dressing should therefore correctly maintain that moisture balance in the wound-bed, while also managing the wound-bed and peri-wound temperatures by maintaining a warm healing environment. In addition, such good dressings should provide mechanical protection to the wound from external or bodyweight forces and also, be tolerant and resistant to these forces so that their structure would not disintegrate during the time of use or while being removed for replacement.

    These expected performances of wound dressings should all be examined objectively, quantitatively and in a standardized manner, through dedicated bioengineering test methods that mimic real-world conditions; the clinical relevance and principles of these tests will be discussed in this talk.

    To apply for CPD after watching on-demand, please email
Email to receive CPD after watching